DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1,653 Cr | ₹1,261 Cr | ₹2,459 Cr | ₹1,912 Cr | ₹1,947 Cr |
What is the latest Cash Flow from Operating Activities ratio of DIVIS LABORATORIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹1,653 Cr |
| Mar2024 | ₹1,261 Cr |
| Mar2023 | ₹2,459 Cr |
| Mar2022 | ₹1,912 Cr |
| Mar2021 | ₹1,947 Cr |
How is Cash Flow from Operating Activities of DIVIS LABORATORIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,653 Cr | 31.09 | |
| Mar2024 | ₹1,261 Cr | -48.72 | |
| Mar2023 | ₹2,459 Cr | 28.62 | |
| Mar2022 | ₹1,912 Cr | -1.80 | |
| Mar2021 | ₹1,947 Cr | - | |
Compare Cash Flow from Operating Activities of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹166,639.7 Cr | -0.2% | 3.8% | 15.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,879.0 Cr | 2.4% | 7.1% | 14.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,431.0 Cr | 1.8% | 10.9% | 48.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,070.0 Cr | 1% | 4% | 16.6% | Stock Analytics | |
| CIPLA | ₹107,051.0 Cr | 0.3% | -0.9% | -6% | Stock Analytics | |
| MANKIND PHARMA | ₹91,161.8 Cr | 0.8% | 7.7% | -2.2% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -0.2% |
3.8% |
15.5% |
| SENSEX | -5% |
-9.6% |
3.1% |
You may also like the below Video Courses